| Original language | English |
|---|---|
| Pages (from-to) | 1347-1349 |
| Number of pages | 3 |
| Journal | Gut |
| Volume | 57 |
| Issue number | 10 |
| DOIs |
|
| State | Published - Oct 2008 |
Natalizumab and PML: A risky business?
Research output: Contribution to journal › Comment/debate
14
Scopus
citations